PRESS RELEASE published on 01/31/2025 at 07:30, 1 year 2 months ago Informations privilégiées / Autres communiqués Poxel annonce les ventes et prévisions de TWYMEEG® au Japon, avec une croissance de 17% au T4 2024 et des ventes prévues à 7,9 milliards de yens pour 2024 Japon Ventes Prévisions Poxel TWYMEEG
BRIEF published on 01/20/2025 at 07:35, 1 year 2 months ago POXEL atteint des ventes majeures avec TWYMEEG® au Japon TWYMEEG® Poxel Sumitomo Pharma Redevances Ventes Japon
BRIEF published on 01/20/2025 at 07:35, 1 year 2 months ago POXEL Achieves Major Sales with TWYMEEG® in Japan Royalties TWYMEEG® Poxel Sumitomo Pharma Japan Sales
PRESS RELEASE published on 01/20/2025 at 07:30, 1 year 2 months ago Informations privilégiées / Autres communiqués Poxel annonce l'atteinte des 5 milliards de yens de ventes nettes de TWYMEEG® au Japon, entraînant des redevances croissantes et un paiement basé sur les ventes. Échéances de remboursement et perspective positive Japon Ventes Nettes Poxel TWYMEEG Redevances
PRESS RELEASE published on 01/20/2025 at 07:30, 1 year 2 months ago Inside Information / Other news releases Poxel to receive sales-based payment and higher royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® achieving JPY 5 billion net sales in Japan. Positive results expected beyond 2024 fiscal year Royalties Poxel Sumitomo Pharma TWYMEEG Sales-based Payment
BRIEF published on 12/23/2024 at 07:35, 1 year 3 months ago Poxel Releases Half-Year Financial Report for 2024 Financial Report 2024 Biopharmaceutical Poxel Audit Review
BRIEF published on 12/23/2024 at 07:35, 1 year 3 months ago Poxel publie son rapport financier semestriel pour 2024 Biopharmaceutique Rapport Financier 2024 Poxel Examen D'audit
PRESS RELEASE published on 12/23/2024 at 07:30, 1 year 3 months ago Half yearly financial reports and audit reports/limited reviews / Terms of availability of the half-yearly financial report Poxel SA announces availability of its 2024 half-year financial report, including condensed financial statements and activities for June 30, 2024 Biopharmaceutical Company Metabolic Disorders MASH 2024 Half-Year Financial Report Poxel SA
PRESS RELEASE published on 12/23/2024 at 07:30, 1 year 3 months ago Rapports financiers et d'audit semestriels/examens réduits / Modalités de mise à disposition du rapport financier semestriel POXEL SA annonce la mise à disposition de son rapport financier semestriel au 30 juin 2024, incluant comptes consolidés, rapport d'activité et attestation Euronext Biopharmaceutique Maladies Métaboliques Rapport Financier Semestriel Poxel SA
PRESS RELEASE published on 12/23/2024 at 07:30, 1 year 3 months ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
Published on 04/02/2026 at 22:00, 3 days 4 hours ago Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 3 days 8 hours ago Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 3 days 11 hours ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 3 days 11 hours ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 3 days 12 hours ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/04/2026 at 10:07, 1 day 16 hours ago Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Published on 04/04/2026 at 02:05, 2 days ago Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 2 days 8 hours ago IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 2 days 8 hours ago IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 2 days 8 hours ago Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 18:46, 2 days 7 hours ago Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 2 days 7 hours ago Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 2 days 8 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 2 days 8 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 2 days 8 hours ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026
